Your browser doesn't support javascript.
loading
The risk of acute myocardial infarction with etodolac is not increased compared to naproxen: a historical cohort analysis of a generic COX-2 selective inhibitor.
Warner, John J; Weideman, Rick A; Kelly, Kevin C; Brilakis, Emmanouil S; Banerjee, Subhash; Cunningham, Francesca; Harford, William V; Kazi, Salahuddin; Little, Bertis B; Cryer, Byron.
  • Warner JJ; Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical School, Dallas, Texas 75390, USA. john.warner@utsouthwestern.edu
J Cardiovasc Pharmacol Ther ; 13(4): 252-60, 2008 Dec.
Article en En | MEDLINE | ID: mdl-18787084
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Naproxeno / Etodolaco / Inhibidores de la Ciclooxigenasa 2 / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País como asunto: America do norte Idioma: En Año: 2008 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Naproxeno / Etodolaco / Inhibidores de la Ciclooxigenasa 2 / Infarto del Miocardio Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged País como asunto: America do norte Idioma: En Año: 2008 Tipo del documento: Article